Crossmark

Synthesis, Anti-Breast Cancer, and EGFR Activity of Novel Pyrido[2,3-d]pyrimidine-piperazine-1,2,4-oxadiazoles

Published Online: 2024-08-16

Published Print: 2024-06

Authors

Jyothi, G.

Palabindela, Rambabu

Narsimha, Sirassu
License Information

Text and Data Mining valid from 2024-06-01

Version of Record valid from 2024-06-01
More Information

Article History

Received: 3 April 2024

Revised: 27 April 2024

Accepted: 30 April 2024

First Online: 16 August 2024

CONFLICT OF INTEREST

: The authors declare no conflict of interest.

Document is current